Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BACHELOR: Baricitinib in Early Polymyalgia Rheumatica
2018-002655-14Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Sep 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in polymyalgia rheumatica (PMR) comparing Baricitinib arm with Placebo arm (2 arms). Started Sep 2019; status: completed.
02
Drugs
baricitinib
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on 2018-002655-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002655-14.